These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22859747)

  • 1. Vascular disease, ESRD, and death: interpreting competing risk analyses.
    Grams ME; Coresh J; Segev DL; Kucirka LM; Tighiouart H; Sarnak MJ
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1606-14. PubMed ID: 22859747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-ESRD Depression and Post-ESRD Mortality in Patients with Advanced CKD Transitioning to Dialysis.
    Molnar MZ; Streja E; Sumida K; Soohoo M; Ravel VA; Gaipov A; Potukuchi PK; Thomas F; Rhee CM; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1428-1437. PubMed ID: 28679562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome, ESRD, and death in CKD.
    Navaneethan SD; Schold JD; Kirwan JP; Arrigain S; Jolly SE; Poggio ED; Beddhu S; Nally JV
    Clin J Am Soc Nephrol; 2013 Jun; 8(6):945-52. PubMed ID: 23411425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.
    Hsu JY; Roy JA; Xie D; Yang W; Shou H; Anderson AH; Landis JR; Jepson C; Wolf M; Isakova T; Rahman M; Feldman HI;
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1181-1189. PubMed ID: 28242844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
    De Nicola L; Minutolo R; Chiodini P; Borrelli S; Zoccali C; Postorino M; Iodice C; Nappi F; Fuiano G; Gallo C; Conte G;
    Kidney Int; 2012 Aug; 82(4):482-8. PubMed ID: 22622495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of CKD patients receiving outpatient nephrology care in Italy.
    De Nicola L; Chiodini P; Zoccali C; Borrelli S; Cianciaruso B; Di Iorio B; Santoro D; Giancaspro V; Abaterusso C; Gallo C; Conte G; Minutolo R;
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2421-8. PubMed ID: 21817127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.
    Obi Y; Kimura T; Nagasawa Y; Yamamoto R; Yasuda K; Sasaki K; Kitamura H; Imai E; Rakugi H; Isaka Y; Hayashi T
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1558-65. PubMed ID: 20558563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
    Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
    Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient characteristics and outcomes by GN subtype in ESRD.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity patterns and the risk for ESRD in postmenopausal women.
    Franceschini N; Gouskova NA; Reiner AP; Bostom A; Howard BV; Pettinger M; Umans JG; Brookhart MA; Winkelmayer WC; Eaton CB; Heiss G; Fine JP
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):241-50. PubMed ID: 25452225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.
    Foster BJ; Mitsnefes MM; Dahhou M; Zhang X; Laskin BL
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):91-99. PubMed ID: 29242373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.
    Saab G; Bomback AS; McFarlane SI; Li S; Chen SC; McCullough PA; Whaley-Connell A;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4414-21. PubMed ID: 23066118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
    Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
    Ravani P; Tripepi G; Malberti F; Testa S; Mallamaci F; Zoccali C
    J Am Soc Nephrol; 2005 Aug; 16(8):2449-55. PubMed ID: 15944335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
    Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
    Berhane AM; Weil EJ; Knowler WC; Nelson RG; Hanson RL
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.
    Lai TS; Lee MH; Yang HI; You SL; Lu SN; Wang LY; Yuan Y; L'Italien G; Chien KL; Chen CJ;
    Hepatology; 2017 Sep; 66(3):784-793. PubMed ID: 28370058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.